Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Financing Activities (2021 - 2025)

PAVmed (PAVM) has 5 years of Cash from Financing Activities data on record, last reported at -$2000.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities changed N/A year-over-year to -$2000.0; the TTM value through Sep 2025 reached $5.9 million, changed N/A, while the annual FY2024 figure was $31.3 million, 0.36% changed from the prior year.
  • Cash from Financing Activities reached -$2000.0 in Q3 2025 per PAVM's latest filing, down from $2.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $60.1 million in Q4 2021 and bottomed at -$2000.0 in Q3 2025.
  • Average Cash from Financing Activities over 5 years is $11.7 million, with a median of $2.8 million recorded in 2025.
  • Peak YoY movement for Cash from Financing Activities: tumbled 99.87% in 2022, then soared 7787.34% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $60.1 million in 2021, then crashed by 99.87% to $80000.0 in 2022, then surged by 6510.0% to $5.3 million in 2023, then plummeted by 93.76% to $330000.0 in 2024, then crashed by 100.61% to -$2000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$2000.0 in Q3 2025, $2.5 million in Q2 2025, and $3.1 million in Q1 2025.